Invoke is a technology investment and advisory company focused on identifying world-leading technology emerging across Europe.
Business Model: B2B
Revenue: $12.3M
Employees: 2-10
Address: 80 Pall Mall
City: London
State: england
Zip: SW1Y 5ES
Country: GB
Invoke Capital Partners was founded by Dr Mike Lynch, members of the senior management team from Autonomy, and a group of technology experts, with access to $1bn in capital. Invoke is focused on maximizing the potential of European fundamental technology by using its unique expertise and repositioning experience to rapidly scale them across multiple markets. It is the only investment team in Europe with a dedicated, in-house R&a;D division, based in Cambridge, UK. The Invoke team has grown multiple technology businesses with particular expertise and experience in science and technology allowing them to identify and develop core technologies in areas including genomics, security, pattern recognition, signal processing and big data.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2015 | Darktrace | Series A | 0 |
1/2019 | Featurespace | Venture Round | 0 |
9/2013 | Darktrace | Venture Round | - |
2/2015 | Neurence | Venture Round | 4M |
2/2019 | Luminance | Series B | 0 |
9/2017 | SOPHiA GENETICS | Series D | 0 |
7/2014 | SOPHiA GENETICS | Series B | 0 |
10/2017 | Featurespace | Venture Round | 0 |
9/2016 | Luminance | Seed Round | 0 |
2/2019 | Luminance | Series B | 0 |
1/2019 | Featurespace | Venture Round | 0 |
10/2017 | Featurespace | Venture Round | 0 |
9/2017 | SOPHiA GENETICS | Series D | 0 |
9/2016 | Luminance | Seed Round | 0 |
3/2015 | Darktrace | Series A | 0 |
2/2015 | Neurence | Venture Round | 0 |
7/2014 | SOPHiA GENETICS | Series B | 0 |
9/2013 | Darktrace | Venture Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|